Sort by
Refine Your Search
-
Listed
-
Category
-
Program
-
Field
-
year project, funded by the DDLS program, we aim to develop AI-based tools in design of affinity ligands, such as the prediction of binding interactions between proteins. Data-driven life science (DDLS
-
School of Engineering Sciences in Chemistry, Biotechnology and Health at KTH Project description Third-cycle subject: Biotechnology This Ph.D. position is in the Division of Systems Biology, part of
-
KTH Royal Institute of Technology, Support services at KTH Would you like to contribute to SciLifeLab’s administrative work in an academic environment? Welcome to apply to SciLifeLab Operations
-
degree in bioinformatics, data science, computer science, scientific computing, or associated field Documented experience with AI methods for analysis of tabular dataset and image-based data including deep
-
collaborative environment where you can both use and develop your technical skills? Then this position may be the perfect fit for you. Requirements University degree in bioinformatics, computer science, IT, or a
-
computer science or an equivalent education, such as a Master of Science in Engineering. A minimum of 10 years of documented experience working in IT as a developer, systems specialist, architect, or similar role
-
can include angles from human genetics, gene regulation, cell biology and computational systems biology. The research group works at the international forefront of human functional genomics, aiming
-
”. Qualification requirements Required Academic degree in Bioinformatics, Computer Science, Biotechnology or similar. Programming experience, preferably using Python or Javascript. Basic knowledge of version control
-
information about us, please visit: the Department of Biochemistry and Biophysics . About the DDLS PhD student program Data-driven life science (DDLS) uses data, computational methods and artificial
-
and accepted to the PhD program at Stockholm University. Project description Project title: “Deep learning modeling of spatial biology data for expression profile-based drug repurposing”. A new exciting